Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

UW Health's Dr. Jeff Pothof discusses FDA-approved food dyes, a new tool to test for HPV at home and the shingles vaccine.

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

Dr. Oz, Administrator of the Centers for Medicare & Medicaid Services, joins MSNBC’s Ari Melber for an extended conversation ...

However, researchers found the reverse was also true, with psychotic episodes nearly doubling the chances a child would be ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

The administration’s “pronatalist” position is substantially at odds with a range of policy decisions that will cause kids to ...